We are pleased to spotlight a newly published, prospective 10-year study in Plastic & Reconstructive Surgery Global Open that followed 716 primary breast-augmentation patients and placed our GCA® implants (including PERLE™). Led by Prof. Berend van der Lei, MD PhD and his team at the University Medical Center Groningen (The Netherlands), the paper—“Key Insights From a Decade of Breast Augmentation: Our Five Critical Decisions in Implant Selection”, documents a decade of clinical vigilance and outstanding outcomes. journals.lww.com
Key findings at 10 years
- Overall revision rate: 1.5 %
- Revisions for size change: 0.03 %
- Five-step, tissue-based planning protocol and 3-D simulation ensured accurate implant choice and consistent inframammary-fold positioning.
GC Aesthetics® is deeply grateful to Prof. van der Lei and his research team for placing their confidence in our implants, and for investing ten years of follow-up to produce truly meaningful evidence. Independent, peer-reviewed science of this calibre elevates the entire field and, most importantly, benefits patients.
Science is our foundation
At GC Aesthetics® we put scientific validation first, supporting and sharing rigorous research so every clinical decision is grounded in solid data.
Total Breast Care™: supporting the whole journey
As The Total Breast Care Company, we equip surgeons and patients at every step:
- EVE 4.0™ 3-D/AR simulation and The Consultation Kit™ for informed, personalised planning
- A comprehensive portfolio of implants and surgical tools for intra-operative precision
- Noa™ postoperative bra plus our lifetime Comfort Plus™ Warranty for confident recovery and lasting peace of mind
Together, these resources give healthcare professionals the quality, choice and assurance they deserve.